TAK-653

9-Methyl--carboline (9-Me-BC) is a synthetic -carboline alkaloid that has drawn nootropic-community interest for a preclinical property that is genuinely unusual among -carbolines: in rodent and cell-culture studies it appears to stimulate the dopaminergic phenotype - raising tyrosine hydroxylase, the number of differentiated dopamine neurons and dopamine content - while also showing neuroprotective, neurorestorative and anti-inflammatory effects, plus in-vitro MAO-A/MAO-B inhibition [PMID:17913302, PMID:20374418, PMID:32285253].

Bromantane is an atypical psychostimulant and anxiolytic developed in the 1980s at the Zakusov Institute of Pharmacology of the Russian Academy of Medical Sciences, originally created as an adaptogen for Soviet military and elite athletic use and later approved in Russia for the treatment of neurasthenic and asthenic disorders under the trade name Ladasten.

Dihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University.

Kavain (kawain) is the principal kavalactone in kava (Piper methysticum) and the main compound behind kava's calming, anxiolytic effect.

KW-6356 is a selective adenosine A2A receptor antagonist/inverse agonist developed by Kyowa Kirin and studied for Parkinson's disease, both as monotherapy and as an add-on to levodopa.

L-Theanine is a non-proteinogenic amino acid found almost exclusively in tea (Camellia sinensis) and a handful of edible mushrooms, and it has become the single most widely-used calm-focus nootropic in the modern supplement market — both on its own at 100-400mg doses and, even more prominently, as the classic 1:1 or 2:1 pair with caffeine that defines the "calm-focus" experiential signature of green tea and of virtually every serious nootropic stack.

TAK-653 (Osavampator / NBI-1065845): The Complete Research Reference

TAK-653 (also called osavampator or NBI-1065845) is an investigational AMPA-receptor positive allosteric modulator designed to enhance glutamate signaling without the seizure liability of older ampakines. This reference covers its mechanism, the real Phase 1 and Phase 2 clinical evidence, how it differs from ketamine and older ampakines, community-reported use, honest safety framing, and where to source it. Research-use-only; not an approved drug.

BHG Labs review: a small, COA-backed nootropics and peptides vendor (2026)

BHG Labs is a small, US-focused research-chemical vendor selling atomized nasal sprays, single-compound nootropic capsules, and lyophilized peptides, all lot-numbered and third-party COA-linked. Everything is research-use-only. The catalog is curated rather than huge, and there's no large public review history yet, so it suits experienced self-experimenters more than first-timers. Code REDDIT takes 10% off.